Reuters logo
BRIEF-La Jolla Pharmaceutical Co announces proposed underwritten public offering of common stock
March 20, 2017 / 8:14 PM / 6 months ago

BRIEF-La Jolla Pharmaceutical Co announces proposed underwritten public offering of common stock

March 20 (Reuters) - La Jolla Pharmaceutical Co

* La Jolla Pharmaceutical Company announces proposed underwritten public offering of common stock

* La Jolla Pharmaceutical Co - announced its intention to offer and sell $100 million of its common stock in an underwritten public offering

* La Jolla Pharmaceutical Co - intends to use net proceeds from underwritten offering for future clinical trials of its drug candidates, among others Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below